The AutoDELFIA® Neonatal 17α-OHP Assay Kit is a state-of-the-art diagnostic tool designed for the accurate and reliable measurement of 17α-hydroxyprogesterone in neonatal blood samples. Utilizing time-resolved fluorescence technology, this kit offers high sensitivity and specificity, making it an essential component in newborn screening programs for congenital adrenal hyperplasia (CAH). The kit includes all necessary components for precise quantification, ensuring consistent and reproducible results.

1. The kit features advanced time-resolved fluorescence technology, which enhances sensitivity and reduces background noise, ensuring accurate detection of low concentrations of 17α-OHP in neonatal blood samples.
2. The composition includes a comprehensive set of reagents and materials, such as calibrators, controls, and specific antibodies, all designed to work seamlessly together to provide reliable and consistent results.
3. The primary use of this kit is in newborn screening programs to detect congenital adrenal hyperplasia (CAH), a condition that can lead to severe health complications if not diagnosed and treated early.

The AutoDELFIA® Neonatal 17α-OHP Assay Kit is a critical tool in the early detection of congenital adrenal hyperplasia. Its advanced technology and comprehensive components ensure accurate and reliable results, making it a trusted choice for neonatal screening programs worldwide.

The AutoDELFIA® Neonatal 17α-OHP Assay Kit offers high sensitivity and specificity, utilizing time-resolved fluorescence technology for accurate measurement of 17α-OHP levels in neonatal blood samples.

1. The kit employs time-resolved fluorescence technology, which significantly enhances the sensitivity and specificity of the assay, allowing for the detection of very low concentrations of 17α-OHP.
2. It includes a complete set of reagents, including calibrators, controls, and specific antibodies, ensuring consistent and reproducible results across different batches.
3. The kit is designed for high-throughput screening, making it suitable for large-scale newborn screening programs.
4. The assay is easy to perform, with a straightforward protocol that minimizes the risk of user error.
5. The kit is compatible with the AutoDELFIA® system, allowing for automated processing and analysis, which increases efficiency and reduces manual labor.

The AutoDELFIA® Neonatal 17α-OHP Assay Kit is a powerful tool for neonatal screening, offering high sensitivity, specificity, and ease of use. Its compatibility with automated systems makes it an efficient choice for large-scale screening programs.

The AutoDELFIA® Neonatal 17α-OHP Assay Kit is primarily used in clinical settings for the early detection of congenital adrenal hyperplasia (CAH) in newborns.

1. The kit is used in newborn screening programs to detect elevated levels of 17α-OHP, which is indicative of congenital adrenal hyperplasia (CAH).
2. Early detection of CAH allows for timely intervention and treatment, preventing severe health complications such as adrenal crisis and ambiguous genitalia.
3. The assay is also used in research settings to study the prevalence and impact of CAH in different populations.
4. The kit's high sensitivity and specificity make it a reliable tool for confirming diagnoses in cases where initial screening results are ambiguous.
5. The assay is used in conjunction with other diagnostic tests to provide a comprehensive evaluation of adrenal function in neonates.

The AutoDELFIA® Neonatal 17α-OHP Assay Kit plays a crucial role in the early detection and management of congenital adrenal hyperplasia. Its clinical applications extend from newborn screening to research, making it an invaluable tool in pediatric endocrinology.

When purchasing the AutoDELFIA® Neonatal 17α-OHP Assay Kit, consider factors such as product specifications, types, budget, and intended use to ensure it meets your needs.

1. Product specifications: Ensure the kit includes all necessary components, such as calibrators, controls, and specific antibodies, and is compatible with your laboratory equipment.
2. Product types: Choose the appropriate kit type based on your screening volume and laboratory capabilities, whether for high-throughput or smaller-scale use.
3. Budget: Consider the cost per test and the overall budget for your screening program, including any additional equipment or reagents needed.
4. Usage scenarios: Evaluate the intended use of the kit, whether for routine newborn screening, research, or diagnostic confirmation, to ensure it aligns with your clinical or research objectives.

Purchasing the AutoDELFIA® Neonatal 17α-OHP Assay Kit requires careful consideration of product specifications, types, budget, and intended use. By aligning these factors with your needs, you can ensure the kit will effectively support your screening or research goals.

When using the AutoDELFIA® Neonatal 17α-OHP Assay Kit, it is important to follow all safety and handling guidelines to ensure accurate results and prevent contamination.

1. Always wear appropriate personal protective equipment (PPE) when handling reagents and samples to prevent exposure and contamination.
2. Ensure all components of the kit are stored at the recommended temperatures to maintain their stability and effectiveness.
3. Follow the assay protocol precisely, including incubation times and reagent volumes, to avoid errors that could affect the accuracy of the results.
4. Regularly calibrate and maintain the equipment used with the kit, such as the time-resolved fluorescence reader, to ensure consistent performance.
5. Dispose of all waste materials according to local regulations and guidelines to prevent environmental contamination and ensure laboratory safety.

Proper handling and use of the AutoDELFIA® Neonatal 17α-OHP Assay Kit are essential for obtaining accurate and reliable results. By adhering to safety guidelines and following the assay protocol, you can ensure the integrity of your screening program and protect the health of laboratory personnel.